Moses CI [Nonparametrics]

posted by Dr Andrew Leary – Ireland, 2009-01-27 12:41 (6346 d 02:55 ago) – Posting: # 3136
Views: 19,555

Thank you both for your responses.

I had not picked up that point during my hasty reading of the new (draft) guideline, Helmut, but saw your extensive discussions of same when looking at the forum yesterday evening.

At present all our BE protocols stick with the old guideline and require non-parametric assessment of Tmax. I can foresee a time in 2 years when we'll have to repeat part of every analysis to provide parametric results. Are you sure that this aspect of the new guideline will stick? I'm a clinician not a statistician, but it seems to me that perfroming parametric stats on a small amount of categorical data flies in the face of traditional teaching.

Kind regards

Andrew

--
Edit: Full quote removed. Please see this post! [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
108 visitors (0 registered, 108 guests [including 25 identified bots]).
Forum time: 16:37 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5